- May 15, 2023, the
project filed for
Chapter 11 bankruptcy,
hours after Athenex,
which was also part of the project,
filed for
bankruptcy as well. Sources:...
- 2022. "
Athenex Announces FDA
Approval of
Klisyri (Tirbanibulin) for the
Treatment of
Actinic Keratosis on the Face or Scalp" (Press release).
Athenex Inc...
- 2021. "
Athenex Announces FDA
Approval of
Klisyri (Tirbanibulin) for the
Treatment of
Actinic Keratosis on the Face or Scalp" (Press release).
Athenex Inc...
- in high
technology and
biotechnology and
currently sits on the
board of
Athenex, a
biopharmaceutical company that had its
initial public offering on June...
- 2020-10-22 9
Sorrento Therapeutics Nasdaq: SRNEQ 2020-5-20 2020-5-20 1
Athenex Nasdaq: ATNXQ 2019-10-22 2019-11-20 10
Pareteum Nasdaq: TEUM 2018-9-6 2019-7-17...
-
Pharmaceutical Lim Sung-ki died of a
chronic disease. He was 80. On May 15, 2023,
Athenex,
which was Hanmi's U.S.
partner for its
anticancer product, Oraxol, filed...
- of May 15, 2023, the last
remaining company started with its funding,
Athenex,
filed for
Chapter 11 bankruptcy.
Alain Kaloyeros, an
American physicist...
- is
developing a cutting-edge
cancer therapy with
American biotech firm
Athenex Inc
wherein the key
technology that the two
sides are
working on are T-cell...
